The Philadelphia chromosome, a chromosomal abnormality that encodes BCR–ABL1, is
the defining lesion of chronic myelogenous leukaemia (CML) and a subset of acute …

This review was commissioned by the World Health Organization (WHO) for the Sexual
Violence Research Initiative (SVRI). This initiative is supported by the Global Forum for Health …

Background Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like ALL) is
characterized by a gene-expression profile similar to that of BCR–ABL1–positive ALL, …

Intrinsic sensitivity of newly diagnosed chronic myeloid leukemia (CML) patients to imatinib (IC50
imatinib ) correlates with molecular response. IC50 imatinib is defined as the in vitro …

As qualitative research becomes increasingly recognized and valued, it is imperative that it
is conducted in a rigorous and methodical manner to yield meaningful and useful results. To …

… We know that colonial white America's perceptions of racial difference were founded on
the different way they constructed black and white women. A body of writing now allows us to …

… and male chauvinism, Deborah Gray White also movingly … inexorable pull of the agendas of
white women and black men. … n't I a Woman, Deborah Gray White has given us a moving and …

Most patients with chronic myeloid leukemia (CML) treated with imatinib will relapse if
treatment is withdrawn. We conducted a prospective clinical trial of imatinib withdrawal in 40 …

Current guidelines for asthma care categorize asthma severity based on the frequency of
asthma symptoms, medication use, and lung function measures. The objective of this study …

Interpatient variability in intracellular uptake and retention (IUR) of imatinib may be due to
variable function of the OCT-1 influx pump. OCT-1 activity was measured in pretherapy blood …